Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD)-Reference-Cited by-同舟云学术

Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD)

Published:2012-03 Issue:1 Volume:316 Page:31-38
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Qiu Yuan,Peng Gui-Lin,Liu Qi-Cai,Li Fu-Li,Zou Xu-Sen,He Jian-Xing

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Current status of immunotherapy for the treatment of lung cancer;Murala;J. Thorac. Dis.,2010

2. Gene therapy for cancer treatment: past, present and future;Cross;Clin. Med. Res.,2006

3. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy;Sterman;Clin. Cancer Res.,2005

4. Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells;Zhang;J. Neurooncol.,2008

5. Effect of local viral transfer of interleukin 10 gene on a rabbit arthritis model induced by interleukin 1β;Zhang;Chin. Med. J.,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surfactants as a means of delivering a reporter genetic construct based on binase suicide gene to tumor cells;Биоорганическая химия;2024-08-19

2. Challenges and Opportunities of Gene Therapy in Cancer;OBM Genetics;2024-03-04

3. Surfactants as a Means of Delivering a Reporter Genetic Construct Based on Binase Suicide Gene to Tumor Cells;Russian Journal of Bioorganic Chemistry;2024-02

4. Applications of tissue-specific and cancer-selective gene promoters for cancer diagnosis and therapy;Advances in Cancer Research;2023

5. Suicide Gene Delivery System Mediated by Ultrasound-Targeted Microbubble Destruction: A Promising Strategy for Cancer Therapy;Human Gene Therapy;2022-12-01